Universitätsklinikum Münster

Analgosedation in cardiology. DGK and DGAI consensus paper 2024 Analgosedierung in der Kardiologie Konsensuspapier der DGK und DGAI 2024 (2024) Tilz RR, Busch S, Chun KR, Frerker C, Gaede L, Steven D, Tiefenbacher C, et al. Journal article Revaskularisation beim diabetischen Fußsyndrom? Wann und wie? (2024) Rother U, Görtz H, Uhl C, Stavroulakis K, Marchiori E, Classen S, Neufang A, et al. Journal article, Review article Targeted and optimized multi-channel transcranial direct current stimulation for focal epilepsy: An N-of-1 trial (2024) Antonakakis M, Kaiser F, Rampp S, Kovac S, Wiendl H, Stummer W, Gross J, et al. Journal article COVID-19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland (2024) Ulrich S, Balmer C, Becker K, Bruhs J, Danne F, Debus V, Dewein L, et al. Journal article Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study (2024) Hägele P, Staus P, Scheible R, Uhlmann A, Heeg M, Klemann C, Maccari ME, et al. Journal article Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL (2024) Stelljes M, Raffel S, Alakel N, Wäsch R, Kondakci M, Scholl S, Rank A, et al. Journal article [Not Available]. (2024) Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, et al. Journal article High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial (2024) Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, et al. Journal article CT-Defined Pectoralis Muscle Density Predicts 30-Day Mortality in Hospitalized Patients with COVID-19: A Nationwide Multicenter Study (2024) Bucher AM, Behrend J, Ehrengut C, Müller L, Emrich T, Schramm D, Akinina A, et al. Journal article Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial. (2024) Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, et al. Journal article